Targeting Glycolytic Reprogramming in Cholangiocarcinoma: A Novel Approach for Metabolic Therapy
Liyuan Hao,1,2,* Shenghao Li,1,2,* Qing Peng,1,2 Junli Zhang,3 Jiali Deng,1,2 Xiaoyu Hu2 1School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, People’s Republic of China; 2Department of ...
Hao L+5 more
doaj
Gastrodin mitigates aortic valve calcification by inhibiting glycolysis and histone lactylation through interfering with valve interstitial cells. [PDF]
Zhang Y+9 more
europepmc +1 more source
ETV4/ALYREF-mediated glycolytic metabolism through PKM2 enhances resistance to ferroptosis and promotes the development of intrahepatic cholangiocarcinoma. [PDF]
Wang X+5 more
europepmc +1 more source
Extracellular PKM2 modulates cancer immunity by regulating macrophage polarity. [PDF]
Peng G+6 more
europepmc +1 more source
miR‐625‐5p/PKM2 negatively regulates melanoma glycolysis state
Hailin Zhang+6 more
openalex +2 more sources
Macrophage regulation of PKM2 during liver regeneration process
Nicolas Mélin+7 more
openalex +1 more source
Mannose inhibits PKM2 lactylation to induce pyroptosis in bladder cancer and activate antitumor immune responses. [PDF]
Jin H+11 more
europepmc +1 more source
THSG counteracts microglial glycolytic reprogramming and neuronal necroptosis both in vivo and in vitro under conditions of neuroinflammation. [PDF]
Guo Z+7 more
europepmc +1 more source
DNMBP-AS1/hsa-miR-30a-5p/PGC1α axis suppresses tumor progression of colorectal cancer by inhibiting PKM2-mediated Warburg effect and enhance anti-PD-1 therapy efficacy. [PDF]
Wang T+12 more
europepmc +1 more source